LifeVantage Appointing Terrence Moorehead as Chief Executive Officer
Rhea-AI Summary
LifeVantage (Nasdaq: LFVN) announced Terrence Moorehead will become President and CEO, and join the board, effective August 5, 2026. Mr. Moorehead brings 25+ years of direct‑selling and consumer products experience, including leading Nature’s Sunshine where revenue rose 45% and EBITDA 190%.
Steve Fife will retire effective April 30, 2026; an interim team will lead the company until Mr. Moorehead assumes the role.
AI-generated analysis. Not financial advice.
Positive
- CEO start date set for August 5, 2026
- 25+ years of leadership experience for incoming CEO
- Nature’s Sunshine track record: Revenue +45%, EBITDA +190%
Negative
- Outgoing CEO retirement creates interim leadership from April 30 to August 5, 2026
- Incoming CEO start is delayed pending completion of prior contractual commitments
News Market Reaction – LFVN
On the day this news was published, LFVN gained 4.60%, reflecting a moderate positive market reaction. This price movement added approximately $3M to the company's valuation, bringing the market cap to $61.21M at that time.
Data tracked by StockTitan Argus on the day of publication.
Key Figures
Market Reality Check
Peers on Argus
LFVN showed a 5.2% pre-news gain while peers were mixed: FTLF, BHST, HAIN were down, BRCC and BYND up. Momentum scanner peers also split between up and down moves, suggesting stock-specific drivers over a unified sector trend.
Historical Context
| Date | Event | Sentiment | Move | Catalyst |
|---|---|---|---|---|
| Apr 09 | Conference participation | Neutral | +3.2% | Management presentation at Water Tower Research Insights Conference for investors. |
| Apr 02 | Market expansion | Positive | +1.2% | Announcement of European footprint expansion with new market opening in Portugal. |
| Mar 16 | Conference participation | Neutral | +0.8% | Sidoti Small Cap Conference appearance with virtual investor meetings and webcast. |
| Feb 04 | Dividend declaration | Positive | -16.8% | Board declaration of quarterly cash dividend as return of capital to shareholders. |
| Feb 04 | CEO succession | Neutral | -16.8% | Planned retirement of CEO Steve Fife and initiation of executive search process. |
Recent company news (expansion, conferences) generally coincided with modest positive moves, while February’s dividend and CEO retirement headlines saw sharp declines.
Over the past six months, LFVN has issued several corporate updates, including conference participation on March 19, 2026 and the Water Tower Research event on April 15, 2026, both followed by modest gains. The planned expansion into Portugal in May 2026 also aligned with a positive price reaction. In contrast, the February 4, 2026 dividend declaration and announcement of Steve Fife’s planned retirement coincided with a notable negative move, framing today’s CEO appointment within an ongoing succession and capital-return backdrop.
Regulatory & Risk Context
An effective S-3 shelf filed on 2026-03-10 allows LFVN to issue up to $75.0 million of securities, including equity, debt, warrants, and units via various offering methods. Usage_count is 0, indicating no takedowns from this shelf as of the latest filings.
Market Pulse Summary
This announcement details LFVN’s CEO succession, naming Terrence Moorehead—who oversaw a 45% revenue increase and 190% EBITDA growth at a prior employer—to take over in August 2026. It follows February’s disclosure of Steve Fife’s planned retirement and interim leadership arrangements. Investors may track how the new CEO’s strategy meshes with recent international expansion plans and how the company balances growth initiatives with its effective $75.0 million shelf capacity.
Key Terms
ebitda financial
AI-generated analysis. Not financial advice.
SALT LAKE CITY, April 16, 2026 (GLOBE NEWSWIRE) -- LifeVantage Corporation (Nasdaq: LFVN) (“LifeVantage” or the “Company”), a leading health and wellness company with products designed to activate optimal health processes at the cellular level, today announced the appointment of Terrence Moorehead as the Company’s new President and Chief Executive Officer and as a member of the Board of Directors (the “Board”), effective August 5, 2026. Mr. Moorehead is expected to commence employment with LifeVantage following the completion of his contractual commitments with his prior employer.
Mr. Moorehead brings more than 25 years of leadership experience revitalizing brands, accelerating customer growth, and delivering sustained financial performance in the direct selling and consumer products industries. He previously served as President and Chief Executive Officer of Nature’s Sunshine Products, Inc. from 2018 through 2025 where he led the company through a multi-year transformation that redefined the business and increased revenue
“Terrence has an outstanding track record of driving growth and scaling leading, global health and wellness brands and we are thrilled to welcome him as our next CEO,” said Raymond Greer, Chairman of the Board of LifeVantage. “Following a comprehensive search process, the Board unanimously concluded that Terrence’s proven ability to lead transformations and his extensive experience in sales, marketing, and finance make him the best choice for the Company and its stockholders, to guide LifeVantage in its next exciting chapter.”
"I'm honored to join LifeVantage at this pivotal moment," said Mr. Moorehead. "The Company’s uniquely differentiated science-backed products, passionate consultant community and dedicated employees create a powerful foundation for the future. I see tremendous potential to further leverage the strong brand position and capabilities and am excited to work alongside the Board and our entire team to sharpen our strategy, drive sustainable growth and deliver meaningful value for our stockholders."
The previously announced retirement of Steve Fife as President, CEO and as a member of the Board is set to take effect on April 30, 2026. In connection with this planned transition, the Board has appointed current director Michael Beindorff as Interim CEO, along with Executive Advisors Kristen Cunningham, Chief Sales Officer, and Carl Aure, Chief Financial Officer, to lead the Company until Mr. Moorehead assumes the role of CEO.
Mr. Greer continued, “On behalf of the entire Board, I want to thank Steve for his leadership and many contributions to LifeVantage over the past nine years. Steve’s vision and dedication were essential in transforming and modernizing our business model, strengthening our financial position, along with expanding our product portfolio and international footprint, ensuring the Company is well positioned for long-term success. We appreciate his commitment to supporting a smooth transition and wish him the very best in his retirement.
“Our interim leadership team comprises highly experienced executives committed to our mission and ensuring continuity for our employees, consultants, and customers. Michael's long history with the Company and strategic perspective as a Board member, combined with the leadership team’s breadth and depth of experience across the entire enterprise, position them well to steward the business through this transition period."
About LifeVantage Corporation
LifeVantage Corporation (Nasdaq: LFVN), the Activation company, is a pioneer in nutrigenomics-the study of how nutrition and naturally occurring compounds can unlock your genes and the health coded within. Our products work with your unique biology and help your body make what it needs for health. The line of scientifically validated activators includes the flagship Protandim® family of products, TrueScience® Liquid Collagen, the MindBody GLP-1 System™, and the comprehensive gut activator P84, and the activation-supporting nutrients such as Omega, D3+, and the Rise AM & Reset PM System®, as well as AXIO® nootropic energy drink mixes, the full TrueScience® line of skin and hair care products, and Petandim®, a pet supplement formulated to combat oxidative stress in dogs. Our independent Consultants sell our products to Customers and share the business opportunity with entrepreneurs seeking to begin their own business. LifeVantage was founded in 2003 and is headquartered in Lehi, Utah. For more information, visit www.lifevantage.com.
Cautionary Note Regarding Forward Looking Statements
This document contains forward-looking statements made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Words and expressions reflecting optimism, satisfaction or disappointment with current prospects, as well as words such as "believe," "will," "hopes," "intends," "estimates," "expects," "projects," "plans," "anticipates," "look forward to," "goal," “may be,” and variations thereof, identify forward-looking statements, but their absence does not mean that a statement is not forward-looking. Examples of forward-looking statements include, but are not limited to, the commencement of Mr. Moorehead’s employment as the Company’s CEO and his service as a director and expectations related to these announcements. Such forward-looking statements are not guarantees of performance and the Company's actual results could differ materially from those contained in such statements. These forward-looking statements are based on the Company's current expectations and beliefs concerning future events affecting the Company and involve known and unknown risks and uncertainties that may cause the Company's actual results or outcomes to be materially different from those anticipated and discussed herein. These risks and uncertainties include, among others, further deterioration to the global economic and operating environments, as well as those discussed in greater detail in the Company's Annual Report on Form 10-K and the Company's Quarterly Report on Form 10-Q under the caption "Risk Factors," and in other documents filed by the Company from time to time with the Securities and Exchange Commission (the “SEC”). The Company cautions investors not to place undue reliance on the forward-looking statements contained in this document. All forward-looking statements are based on information currently available to the Company on the date hereof, and the Company undertakes no obligation to revise or update these forward-looking statements to reflect events or circumstances after the date of this document, except as required by law.
Investor Relations Contacts:
Reed Anderson, ICR
(646) 277-1260
reed.anderson@icrinc.com
